Compounds > nylidrin
Page last updated: 2024-11-01

nylidrin and Abnormalities, Congenital

nylidrin has been researched along with Abnormalities, Congenital in 1 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eggimann, UH1
Thürig, E1
Moser, H1
Bossi, E1

Other Studies

1 other study available for nylidrin and Abnormalities, Congenital

ArticleYear
[Threatened abortion: patient characteristics, treatment results and consequences for the child].
    Schweizerische medizinische Wochenschrift, 1979, Feb-24, Volume: 109, Issue:8

    Topics: Abortion, Threatened; Congenital Abnormalities; Diazepam; Dydrogesterone; Female; Hexestrol; Humans;

1979